Asia
Rendu Biotech's Controlling Shareholder Eyes Share Transfer Deal
Shanghai Rendu Biotechnology (SHA:688193) is facing a potential change in control amid its controlling shareholder's plan to carry out a major share transfer agreement, according to a Shanghai bourse filing on Friday.Trading of the Chinese biotechnology product maker's shares was suspended on Friday to prevent price volatility amid ongoing control-transfer negotiations. The halt is expected to last for two days.
SHA:688193
